Apples WWDC AI Showcase Could Determine Stocks Next Move
Ohio Woman Discovers ExBoyfriend Secretly Charged Nearly 17000 to Her Credit Cards Ramsey Show Advises Treating It as Fraud
SP 500 Edges Higher Led by Healthcare and Tech Communication Services Lags
Hajj 2026 Over 15 Million Foreign Pilgrims Arrive in Saudi Arabia Amid Regional Tensions
NARCL Retains Guarantees of Jaypee ExPromoters to Boost Dues Recovery
Toronto Blue Jays Legend Passes at Age Age Unknown from Source
GM Q1 2026 Earnings Earnings Per Share Smashes Estimates Driving Optimism
Pineapple Financial Inc PAPL Q3 2025 Earnings SmallerThanExpected Loss Highlights Cost Discipline Amid Revenue Uncertainty
ABVX Q4 2025 Earnings Significant EPS Miss as DevelopmentStage Biotech Reports WiderThanExpected Loss
Annexon Inc ANNX Q1 2026 Earnings NarrowerthanExpected Loss Highlights Cost Discipline but No Revenue Yet
NewAmsterdam Pharma NAMS Q1 2026 Earnings Narrowerthanexpected loss as biotech advances pipeline
CACI Q1 2026 Earnings EPS Beat Drives Positive Early Trading
MACOM Technology Solutions MTSI Shares Decline 258 as Tech Sector Headwinds Persist
Henry Schein HSIC Rallies 24 as Shares Approach Key Resistance Level
Muzero Acquisition Corp Unit MUZEU Holds Steady at 1003 as SPAC Unit Trades in Tight Range
Upexi Inc UPXI Slides 3 as Shares Test Key Support Near 123
Larimar Therapeutics LRMR Edges Higher as Biotech Stock Hovers Near Key Resistance
Stellantis Turnaround Plan Prediction Market Regulation Oura IPO Filing Morning Market Movers
SIGA Q1 2026 Earnings Net Loss of 005 per Share as Revenue Figures Remain Undisclosed
Coeptis Therapeutics Warrants COEPW Hold Steady at 001 MicroCap Warrant in Stalemate
NTIP Q1 2026 Earnings Net Loss of 002 Reported Stock Dips 067
F Q1 2026 Earnings Massive EPS Beat Drives 922 Stock Surge
RFIL Q1 2026 Earnings Strong EPS Beat of 96 Surprises Analysts
ReNew Energy Global plc RNW Q1 2026 Earnings EPS Surges Past Estimates as Profitability Improves
APWC Q3 1997 Earnings EPS Misses Estimates by 287 Stock Declines
QURE Q1 2026 Earnings NarrowerthanExpected Loss as Gene Therapy Developer Continues Pipeline Progress
Workday Q1 2026 Earnings EPS Beat Drives Solid Stock Rally